论文部分内容阅读
目的:探讨分析异甘草酸镁注射液治疗肝病的临床效果,并对其安全性进行评价。方法:选取在我院接受治疗的98例肝病患者作为研究对象,按照治疗方法将其分为A组和B组,每组各49例,A组采用异甘草酸镁注射液进行治疗,B组采用复方甘草酸苷注射液进行治疗,疗程结束后,对比分析两组患者的临床治疗效果以及不良反应发生率。结果:通过对比发现,A组患者的临床治疗效果高于B组,不良反应发生率低于B组,且差异明显,具有统计学意义(P<0.05)。结论:采用异甘草酸镁注射液治疗肝病效果显著,安全性较高且患者不良反应发生率低,值得临床推广应用。
Objective: To investigate the clinical effect of magnesium isrimazole injection in the treatment of liver disease and to evaluate its safety. Methods: A total of 98 patients with liver disease who were treated in our hospital were selected as study objects. According to the treatment methods, they were divided into group A and group B, 49 cases in each group. Group A was treated with magnesium glycyrrhizinate injection. Group B received compound licorice Acid glucoside injection for treatment, after the end of treatment, comparative analysis of two groups of patients with clinical treatment and adverse reaction rates. Results: The results showed that the clinical efficacy of group A was higher than that of group B, the incidence of adverse reactions was lower than that of group B, and the difference was significant (P <0.05). Conclusion: The treatment of liver disease with magnesium glycyrrhizinate injection has obvious effect, high safety and low incidence of adverse reactions in patients, which is worthy of clinical application.